Pacira BioSciences, Inc. (PCRX)

NASDAQ: PCRX · Real-Time Price · USD

24.67

+0.84 (3.52%)

At close: Aug 21, 2026, 4:00 PM EDT

24.18

-0.49 (-1.99%)

After-hours: Aug 21, 2026, 6:29 PM EDT

Pacira BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	205.88	158.55	276.77	153.3	104.14	585.58
Short-Term Investments	45.16	79.88	207.84	125.28	184.51	70.83
Cash & Short-Term Investments	251.03	238.42	484.62	278.58	288.65	656.41
Cash Growth	-43.70%	-50.80%	73.96%	-3.49%	-56.03%	25.83%
Accounts Receivable	132.42	124.07	113.3	105.56	98.4	96.32
Other Receivables	8.6	0.3	0.5	0.4	0.8	0.1
Receivables	141.02	124.37	113.8	105.96	99.2	96.42
Inventory	134.58	152.86	125.28	104.35	96.06	98.55
Prepaid Expenses	21.25	30.62	20.43	20.4	14.32	14.67
Other Current Assets	67.34	1.7	1	0.7	0.1	-
Total Current Assets	615.22	547.97	745.13	509.99	498.33	866.05
Property, Plant & Equipment	175.2	182.47	216.39	234.95	254.39	264.81
Long-Term Investments	7.75	16.31	29.45	32.26	60.18	21.99
Goodwill	19.64	20.21	-	163.24	163.24	145.18
Other Intangible Assets	285.48	368.1	425.97	483.26	540.55	623.97
Long-Term Deferred Tax Assets	124.6	123.85	130.38	144.49	160.31	153.36
Other Long-Term Assets	13.59	6	6.2	6.2	4.2	-
Total Assets	1,244	1,265	1,554	1,574	1,681	2,075

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	17.51	15.15	19.13	15.7	15.22	10.54
Accrued Expenses	80.82	84.05	69.52	55.72	82.49	118.6
Current Portion of Long-Term Debt	-	-	201.78	8.64	33.65	374.7
Current Portion of Leases	10.3	9.84	8.89	8.8	9.12	7.89
Current Income Taxes Payable	-	-	-	-	-	0.43
Other Current Liabilities	13.39	11.55	10.61	8.53	7.3	8.95
Total Current Liabilities	122.01	120.59	309.92	97.38	147.77	521.12
Long-Term Debt	363.12	372.19	383.55	513.8	655.82	674.53
Long-Term Leases	38.7	36.18	44.65	54.81	64.8	71.73
Long-Term Deferred Tax Liabilities	4.07	4.21	-	-	-	-
Other Long-Term Liabilities	44.1	38.64	37.06	38.27	37.79	77.57
Total Liabilities	572	571.81	775.17	704.26	906.19	1,345

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.05	0.05	0.05	0.05	0.05	0.05
Additional Paid-In Capital	1,087	1,065	1,009	976.63	924.1	942.09
Retained Earnings	-191.75	-199.32	-206.36	-106.8	-148.75	-211.9
Treasury Stock	-227.01	-176.57	-25.12	-	-	-
Comprehensive Income & Other	3.24	4.33	0.34	0.25	-0.38	0.17
Shareholders' Equity	671.98	693.11	778.35	870.13	775.01	730.41
Total Liabilities & Equity	1,244	1,265	1,554	1,574	1,681	2,075

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	412.12	418.2	638.85	586.04	763.39	1,129
Net Cash (Debt)	-161.09	-179.78	-154.24	-307.46	-474.74	-472.44
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-3.80	-3.99	-3.34	-5.92	-10.20	-10.35
Filing Date Shares Outstanding	39.86	40.49	46.28	46.5	45.95	44.85
Total Common Shares Outstanding	39.82	41.12	46.24	46.48	45.93	44.73
Working Capital	493.2	427.38	435.21	412.61	350.56	344.93
Book Value Per Share	16.87	16.86	16.83	18.72	16.87	16.33
Tangible Book Value	366.85	304.8	352.38	223.63	71.22	-38.74
Tangible Book Value Per Share	9.21	7.41	7.62	4.81	1.55	-0.87
Machinery	191.92	191.46	186.07	141.5	136.46	133.34
Construction In Progress	11.58	9.49	28	105.91	103.23	80.56
Leasehold Improvements	77.65	77.45	86.03	61.83	61.3	59.74

SEC Filings: 10-K · 10-Q